Joe Ninosky

Joe Ninosky is an experienced professional in the life sciences industry with over 20 years of expertise in drug substance process development and analytical method development. Currently the Owner and Founder of Symbiotx, Ninosky provides critical CMC insights for pharmaceutical product development. Previous roles include Vice President of CMC at Biotheryx, Inc. and Revelation Biosciences Inc., and Senior Director of Chemical Engineering at TriLink BioTechnologies, where significant contributions included the successful scale-up of processes related to COVID-19 vaccine production. Ninosky holds a Master’s degree in Chemical Engineering and several certifications in Six Sigma and project management, reflecting a strong commitment to leadership, innovation, and process optimization in biopharmaceutical development.